Search results for: 'security analytics ad siem'

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...

25 Jun 2021  |  Asia Pacific  |  Market Research

Asia-Pacific Cloud Workload Protection Growth Opportunities

Increasing Multi-Cloud Adoption Drives Investment in Dedicated CWP Solutions

Infographics

×

Driven by digital transformation requirements, the trend of companies migrating to the cloud rose worldwide over the last few years and is likely to accelerate in the next few years. More businesses embarked on the cloud journey to support remote workers and quickly adapt to the requirements and challenges of the COVID-19 pandemic, another facto...

21 May 2021  |  Global  |  Market Research

Global Command and Control Software Growth Opportunities

Customer Experience Drives Future Growth Strategies in the Airports, Safe Cities, and Critical National Infrastructure Verticals

Infographics

×

Most companies have operated their physical and digital security teams, data, and systems in silos. While security convergence is a prevalent industry trend, it has gained popularity in recent years as threats became more complex. Security systems are increasingly digitized, connected, and integrated. Demand for integrated command and control c...

In the age of rising digitalization and Industry 4.0 initiatives, the quest to maintain the highest security possible is ongoing. The global ICS cybersecurity market is witnessing steady growth, with companies focused on enhancing the security and resilience of critical industrial assets. Industrial companies seek to secure and optimize their Oper...

Water utilities across the globe are exploring new solutions to adapt to climate change, this has driven decision makers to implement water conservation policies which specifies the need to reduce leaks and holistically reduce Non-Revenue Water (NRW). Smart water meters are the tool of choice for water utilities to reduce leaks and NRWas it ensures...

This trend opportunity profile covers the global aspects of banking and financial services, featuring the most upcoming trends that cater to the BFS industry. In addition, the study describes the opportunities for several sectors, such as FMCG, retail, ICT, businesses, and financial services. Trend opportunity profile series covers specific opportu...

01 Sep 2020  |  North America  |  Market Research

Oncology Information Systems to Drive Robustness in Care Delivery, Forecast to 2024

Future Growth Potential Lies in Precision Medicine and Cloud Adoption in Oncology Care

Infographics

×

As cancer care becomes increasingly highly complex, the information, image data, and steps that comprise a single patients healthcare journey has grown tremendously. Oncology information systems (OIS) software are used by cancer clinics and departments, medical oncologists, radiation specialists, and department employees to manage and plan the trea...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...